Asia-Pacific Ocular Pain Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Oct 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 324
  • No of Figures: 56

Asia-Pacific Ocular Pain Market, By Disease Type (Ocular Pain with Eye Diseases and Ocular Pain without Primary Eye Diseases), Type (Diagnosis and Treatment), Application (Conjunctivitis, Corneal Abrasion, Blepharitis, Sty, Iritis, Sinusitis, Migraines, Glaucoma, and Others), Route of Administration (Topical, Periocular, Intraocular, Oral and Others), Drug Type (Prescription and Over the Counter), Population Type  (Adults and Geriatric), End User (Hospitals, Specialty Clinics, Home Healthcare Settings, Ophthalmology Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Vietnam and Rest of Asia-Pacific) – Industry Trends and Forecast to 2028. 

Asia-Pacific Ocular Pain Market Market Analysis and Insights: Asia-Pacific Ocular Pain Market

Asia-Pacific ocular pain market is expected to grow in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the highest CAGR of 9.0% in the forecast period of 2021 to 2028 and is expected to reach USD 322.76 million by 2028. Increasing unhygienic and sedentary lifestyle acts as a driver for the Asia-Pacific ocular pain market growth.

Ocular pain also, known as eye pain, commonly occurs due to mild irritation, but it is rarely a symptom of a serious condition. Mostly the pain resolves without medicine or further treatment, and it recovers by the self-immune system. However, ocular pain with underlying primary ophthalmic disorders requires timely treatment. Eye pains are generally categorized under two categories, such as ocular pain, which occurs over the eye's surface, creating sensations of scratching, burning, or itching. They are caused due to a person’s eyelashes, foreign objects, infection, or trauma. Often ocular pain is treated with eye drops and topical steroids or NSAIDs. Ocular pain occurs with underlying primary eye diseases like conjunctivitis, contact lens irritation, corneal abrasion, injury, blepharitis, and sty. The other advanced treatments, like stimulation therapies, are also used for severe neuro ocular pain, appropriately diagnosed.

Increasing unhygienic and sedentary lifestyles, rising prevalence of ophthalmic disorders, and ocular pain act as drivers for the Asia-Pacific ocular pain market. The increasing awareness among people for eye-related diseases and growing cases of ocular migraine is further boosting the market growth. The side effects of eye treatment medicines and the high cost of eye treatment and medication are restraining the growth of the Asia-Pacific ocular pain market. Increasing research and development activities, rising healthcare expenditure and disposable income, and a growing geriatric population act as opportunities for the Asia-Pacific ocular pain market. Lack of healthcare facilities for eye treatment and stringent regulatory framework poses a challenge for the Asia-Pacific ocular pain market growth.

The Asia-Pacific ocular pain market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the ocular pain market scenario, contact Data Bridge Market Research for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Ocular Pain Market Asia-Pacific Ocular Pain Market Scope and Market Size

Asia-Pacific ocular pain market is segmented based on disease type, type, applications, route of administration, drug type, population type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of disease type, the Asia-Pacific ocular pain market is segmented into ocular pain with eye diseases and ocular pain without primary eye diseases. In 2021, the ocular pain with eye diseases segment is expected to dominate the ocular pain market due to rising awareness about ophthalmic conditions among the public.
  • On the basis of type, the Asia-Pacific ocular pain market is segmented into diagnosis and treatment. In 2021, the diagnosis segment is expected to dominate the market as research activities in Asia countries and institutes are surging.
  • On the basis of application, the Asia-Pacific ocular pain market is segmented into conjunctivitis, corneal abrasion, blepharitis, sty, iritis, sinusitis, migraines, glaucoma, and others. In 2021, the glaucoma segment is expected to dominate the market as the disease's prevalence is high in developing countries of the region.
  • On the basis of route of administration, the Asia-Pacific ocular pain market is segmented into topical, periocular, intraocular, oral, and others. In 2021, the topical segment is expected to dominate the market due to high patient compliance.
  • On the basis of drug type, the Asia-Pacific ocular pain market is segmented into prescription and over the counter. In 2021, the prescription segment is expected to dominate the market due to heavy stringent regulatory administrations over the region.
  • On the basis of population type, the Asia-Pacific ocular pain market is segmented into adults and geriatric. In 2021, the adults segment is expected to dominate the market due to multiple gadgets and less eye care protection.
  • On the basis of end user, the Asia-Pacific ocular pain market is segmented into hospitals, specialty clinics, home healthcare, ophthalmology centers, ambulatory surgical centers, and others. In 2021, the hospitals segment is expected to dominate the market due to high healthcare expenditure and hospital construction.
  • On the basis of distribution channel, the Asia-Pacific ocular pain market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, and others. In 2021, the direct tender segment is expected to dominate the market as they specifically provide products per customers' needs with user benefits.

Asia-Pacific Ocular Pain Market Country Level Analysis

Asia-Pacific ocular pain market is analyzed, and market size information is provided by the country, disease type, type, applications, route of administration, drug type, population type, end user, and distribution channel as referenced above.

The countries covered in the Asia-Pacific ocular pain market report are China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, and the Rest of Asia-Pacific.

The prescription segment in Japan of the Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing cases of ophthalmic disorders. The prescription segment in China is the second dominating market owing to the increasingly sedentary lifestyle of people. India is the third leading market in the Asia-Pacific region. The prescription segment is expected to dominate in this country due to the highest number of ophthalmology hospitals.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Ocular Pain Treatment is Boosting the Market Growth of the Asia-Pacific Ocular Pain Market

Asia-Pacific ocular pain market also provides you with a detailed market analysis for every country's growth in the particular market. Additionally, it provides detailed information regarding the market players’ strategy and their geographical presence. The data is available for the historical period 2010 to 2019.

Competitive Landscape and Asia-Pacific Ocular Pain Market Share Analysis

Asia-Pacific ocular pain market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Asia-Pacific ocular pain market.

The major companies which are dealing in the Asia-Pacific ocular pain market are Johnson & Johnson Services, Inc., Pfizer Inc., Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., AERIE PHARMACEUTICALS, INC., Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Novartis AG, Allergan (An AbbVie Company)., Formosapharma Pharmaceutical Inc.,  and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contracts and agreements are also initiated by companies worldwide, which accelerate the Asia-Pacific ocular pain market.

For instance,

  • In September 2021, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., announced that the company participated in a virtual fireside chat at the Morgan Stanley 19th Annual Conference. This helped company in gaining attraction of more Asia-Pacific customers
  • In May 2019, Pfizer Inc. expanded its business by opening a new manufacturing facility in Andover, Massachusetts. The company has adopted this initiative to boost up the manufacturing of pharmaceutical products to improve patient’s treatment options. This initiative allowed the company to build up a strong partnership with the research and development manufacturing teams

Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player enhance the company's footprints in the ocular pain market, which also benefits the organization’s profit growth.

Customization Available: Asia-Pacific Ocular Pain Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 AVERAGE PRICING ANALYSIS OF VARIOUS TREATMENT PRODUCTS

TABLE 2 VOLUME OF PRESCRIPTION (%)

TABLE 3 ASIA PACIFIC OCULAR PAIN MARKET, PIPELINE ANALYSIS

TABLE 4 ASIA PACIFIC OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 5 ASIA PACIFIC OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 ASIA PACIFIC OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 7 ASIA PACIFIC OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 ASIA PACIFIC OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 9 ASIA PACIFIC OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 10 ASIA PACIFIC DIAGNOSIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA PACIFIC DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 12 ASIA PACIFIC SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 13 ASIA PACIFIC IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 ASIA PACIFIC TREATMENT IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA PACIFIC TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 ASIA PACIFIC LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 17 ASIA PACIFIC TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 ASIA PACIFIC NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 19 ASIA PACIFIC STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 20 ASIA PACIFIC OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 21 ASIA PACIFIC GLAUCOMA IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA PACIFIC BLEPHARITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA PACIFIC CONJUNCTIVITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA PACIFIC CORNEAL ABRASION IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 ASIA PACIFIC STY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA PACIFIC IRITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA PACIFIC SINUSITIS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA PACIFIC MIGRAINES IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA PACIFIC OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA PACIFIC OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 31 ASIA PACIFIC TOPICAL IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA PACIFIC TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 33 ASIA PACIFIC INTRAOCULAR IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 ASIA PACIFIC INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 35 ASIA PACIFIC PERIOCULAR IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 ASIA PACIFIC PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 37 ASIA PACIFIC ORAL IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 ASIA PACIFIC ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 39 ASIA PACIFIC OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 ASIA PACIFIC OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 41 ASIA PACIFIC PRESCRIPTION IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 ASIA PACIFIC OVER THE COUNTER IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 ASIA PACIFIC OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 44 ASIA PACIFIC ADULTS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 ASIA PACIFIC GERIATRIC IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 ASIA PACIFIC OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 47 ASIA PACIFIC HOSPITALS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 ASIA PACIFIC SPECIALTY CLINICS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 49 ASIA PACIFIC HOME HEALTHCARE IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 ASIA PACIFIC OPHTHALMOLOGY CENTERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 ASIA PACIFIC OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 53 ASIA PACIFIC OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 ASIA PACIFIC DIRECT TENDER IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 ASIA PACIFIC HOSPITAL PHARMACY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 56 ASIA PACIFIC RETAIL PHARMACY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 ASIA PACIFIC ONLINE PHARMACY IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 58 ASIA PACIFIC OTHERS IN OCULAR PAIN MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 59 ASIA-PACIFIC OCULAR PAIN MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 60 ASIA-PACIFIC OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 61 ASIA-PACIFIC OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 62 ASIA-PACIFIC OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 63 ASIA-PACIFIC OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 ASIA-PACIFIC DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 ASIA-PACIFIC SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 ASIA-PACIFIC IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 67 ASIA-PACIFIC TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 ASIA-PACIFIC LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 ASIA-PACIFIC TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 70 ASIA-PACIFIC NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 71 ASIA-PACIFIC STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 72 ASIA-PACIFIC OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 ASIA-PACIFIC OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 74 ASIA-PACIFIC TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 75 ASIA-PACIFIC INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 76 ASIA-PACIFIC PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 77 ASIA-PACIFIC ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 78 ASIA-PACIFIC OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 79 ASIA-PACIFIC OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 80 ASIA-PACIFIC OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 ASIA-PACIFIC OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 82 JAPAN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 83 JAPAN OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 84 JAPAN OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 85 JAPAN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 JAPAN DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 87 JAPAN SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 JAPAN IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 JAPAN TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 JAPAN LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 JAPAN TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 JAPAN NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 93 JAPAN STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 94 JAPAN OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 95 JAPAN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 96 JAPAN TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 97 JAPAN INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 98 JAPAN PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 99 JAPAN ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 100 JAPAN OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 101 JAPAN OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 102 JAPAN OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 103 JAPAN OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 104 CHINA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 105 CHINA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 106 CHINA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 107 CHINA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 CHINA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 109 CHINA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 CHINA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 111 CHINA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 112 CHINA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 113 CHINA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 114 CHINA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 115 CHINA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 CHINA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 117 CHINA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 118 CHINA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 119 CHINA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 120 CHINA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 121 CHINA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 122 CHINA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 123 CHINA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 124 CHINA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 125 CHINA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 126 INDIA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 127 INDIA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 128 INDIA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 129 INDIA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 130 INDIA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 131 INDIA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 132 INDIA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 133 INDIA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 134 INDIA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 135 INDIA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 136 INDIA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 137 INDIA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 INDIA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 139 INDIA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 140 INDIA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 141 INDIA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 142 INDIA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 143 INDIA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 144 INDIA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 145 INDIA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 146 INDIA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 147 INDIA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 148 SOUTH KOREA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 149 SOUTH KOREA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 150 SOUTH KOREA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 151 SOUTH KOREA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 152 SOUTH KOREA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 153 SOUTH KOREA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 154 SOUTH KOREA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 155 SOUTH KOREA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 156 SOUTH KOREA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 157 SOUTH KOREA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 158 SOUTH KOREA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 159 SOUTH KOREA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 160 SOUTH KOREA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 161 SOUTH KOREA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 162 SOUTH KOREA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 163 SOUTH KOREA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 164 SOUTH KOREA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 165 SOUTH KOREA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 166 SOUTH KOREA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 167 SOUTH KOREA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 168 SOUTH KOREA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 169 SOUTH KOREA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 170 AUSTRALIA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 171 AUSTRALIA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 172 AUSTRALIA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 173 AUSTRALIA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 174 AUSTRALIA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 175 AUSTRALIA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 176 AUSTRALIA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 177 AUSTRALIA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 178 AUSTRALIA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 179 AUSTRALIA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 180 AUSTRALIA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 181 AUSTRALIA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 182 AUSTRALIA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 183 AUSTRALIA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 184 AUSTRALIA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 185 AUSTRALIA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 186 AUSTRALIA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 187 AUSTRALIA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 188 AUSTRALIA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 189 AUSTRALIA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 190 AUSTRALIA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 191 AUSTRALIA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 192 SINGAPORE OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 193 SINGAPORE OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 194 SINGAPORE OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 195 SINGAPORE OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 196 SINGAPORE DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 197 SINGAPORE SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 198 SINGAPORE IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 199 SINGAPORE TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 200 SINGAPORE LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 201 SINGAPORE TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 202 SINGAPORE NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 203 SINGAPORE STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 204 SINGAPORE OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 205 SINGAPORE OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 206 SINGAPORE TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 207 SINGAPORE INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 208 SINGAPORE PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 209 SINGAPORE ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 210 SINGAPORE OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 211 SINGAPORE OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 212 SINGAPORE OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 213 SINGAPORE OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 214 THAILAND OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 215 THAILAND OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 216 THAILAND OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 217 THAILAND OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 218 THAILAND DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 219 THAILAND SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 220 THAILAND IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 221 THAILAND TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 222 THAILAND LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 223 THAILAND TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 224 THAILAND NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 225 THAILAND STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 226 THAILAND OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 227 THAILAND OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 228 THAILAND TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 229 THAILAND INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 230 THAILAND PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 231 THAILAND ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 232 THAILAND OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 233 THAILAND OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 234 THAILAND OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 235 THAILAND OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 236 MALAYSIA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 237 MALAYSIA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 238 MALAYSIA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 239 MALAYSIA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 240 MALAYSIA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 241 MALAYSIA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 242 MALAYSIA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 243 MALAYSIA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 244 MALAYSIA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 245 MALAYSIA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 246 MALAYSIA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 247 MALAYSIA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 248 MALAYSIA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 249 MALAYSIA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 250 MALAYSIA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 251 MALAYSIA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 252 MALAYSIA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 253 MALAYSIA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 254 MALAYSIA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 255 MALAYSIA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 256 MALAYSIA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 257 MALAYSIA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 258 INDONESIA OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 259 INDONESIA OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 260 INDONESIA OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 261 INDONESIA OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 262 INDONESIA DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 263 INDONESIA SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 264 INDONESIA IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 265 INDONESIA TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 266 INDONESIA LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 267 INDONESIA TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 268 INDONESIA NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 269 INDONESIA STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 270 INDONESIA OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 271 INDONESIA OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 272 INDONESIA TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 273 INDONESIA INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 274 INDONESIA PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 275 INDONESIA ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 276 INDONESIA OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 277 INDONESIA OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 278 INDONESIA OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 279 INDONESIA OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 280 PHILIPPINES OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 281 PHILIPPINES OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 282 PHILIPPINES OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 283 PHILIPPINES OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 284 PHILIPPINES DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 285 PHILIPPINES SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 286 PHILIPPINES IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 287 PHILIPPINES TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 288 PHILIPPINES LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 289 PHILIPPINES TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 290 PHILIPPINES NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 291 PHILIPPINES STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 292 PHILIPPINES OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 293 PHILIPPINES OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 294 PHILIPPINES TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 295 PHILIPPINES INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 296 PHILIPPINES PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 297 PHILIPPINES ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 298 PHILIPPINES OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 299 PHILIPPINES OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 300 PHILIPPINES OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 301 PHILIPPINES OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 302 VIETNAM OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 303 VIETNAM OCULAR PAIN WITH EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 304 VIETNAM OCULAR PAIN WITHOUT PRIMARY EYE DISEASES IN OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

TABLE 305 VIETNAM OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 306 VIETNAM DIAGNOSIS IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 307 VIETNAM SENSORY TESTING IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 308 VIETNAM IMAGING TEST IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 309 VIETNAM TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 310 VIETNAM LOCAL TREATMENT IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 311 VIETNAM TOPICAL STEROID IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 312 VIETNAM NONSTEROIDAL ANTI-INFLAMMATORY (NSAID) IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 313 VIETNAM STIMULATION THERAPIES IN OCULAR PAIN MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 314 VIETNAM OCULAR PAIN MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 315 VIETNAM OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 316 VIETNAM TOPICAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 317 VIETNAM INTRAOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 318 VIETNAM PERIOCULAR IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 319 VIETNAM ORAL IN OCULAR PAIN MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 320 VIETNAM OCULAR PAIN MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 321 VIETNAM OCULAR PAIN MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 322 VIETNAM OCULAR PAIN MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 323 VIETNAM OCULAR PAIN MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 324 REST OF ASIA-PACIFIC OCULAR PAIN MARKET, BY DISEASE TYPE, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions